4D Molecular Therapeutics, Inc. (FDMT)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
14. 35
+0.24
+1.7009%
$
737.62M Market Cap
- P/E Ratio
- Div Yield
684,262 Volume
-3.06 Eps
$ 14.11
Previous Close 
Want to track FDMT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
4D Molecular Therapeutics, Inc. (FDMT) Statistics
Valuation metrics
Market Cap 737.62M
Enterprise value 735.74M
Trailing P/E (ttm) -5.39
Forward P/E -
PEG ratio -0.37
Price/Sales (ttm) 8.34
Price/Book (mrq) 2.53
Enterprise Value/Revenue 8
Enterprise Value/EBITDA -3.98
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.37M
Average volume (90 days) 783.56K
Price summary
52-Week low 5.97
52-Week high 16.93
Beta -
50-Day moving average 11.33
200-Day moving average 9.73
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.95%
Operating margin -2.14%
Operational effectiveness
Return on assets -0.36%
Return on equity -0.41%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.31
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.55
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.14
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 8.03%
Book value per share (mrq) 5.8
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
